Research Paper Volume 16, Issue 1 pp 820—843
Prognostic implication of a novel lactate score correlating with immunotherapeutic responses in pan-cancer
Figure 3. The prognostic value of LDHA in pan-cancers. (A) The expression of LDHA did not significantly correlate with overall survival in some cancers with high-frequency mutations in LRGs. (B) The KM plot of patients with high, middle and low LDHA in BRCA. (C) The KM plot of patients with high, middle and low LDHA in OV. In each cancer patients were equally divided into three groups of high, middle and low according to their LDHA expression. BRCA: breast invasive carcinoma; OV: ovarian cancer.